Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue covers both the in vitro and in vivo evaluation of marine carotenoids with anti-inflammatory and anticancer activities as well as clinical trials conducted in humans. Among the properties of carotenoids discussed in this book, it is worth highlighting the potential of astaxanthin and its precursor metabolite, adonixanthin, since oral administration of these carotenoids has shown beneficial effects on glioblastoma for the first time by suppressing cell proliferation and migration. In addition, astaxanthin has been shown to inhibit Helicobacter pylori-induced gastric carcinoma cell motility and, consequently, cancer progression through the inhibition of cytoskeleton reorganization. In addition, a carotenoid-containing lipid extract of Gloeothece sp. has demonstrated antioxidant, anti-inflammatory, and anticancer properties in vitro.

Helicobacter pylori --- gastric carcinoma --- astaxanthin --- cell motility --- cell migration --- bioavailability --- carotenoids --- marine --- nanoformulation --- oxidative stress --- reactive oxygen species --- brain --- cancer --- oral administration --- paracoccsu carotinifaciens --- xanthophyll carotenoid --- photodamage --- skin cancer --- photoaging --- marine carotenoids --- fucoxanthin --- xanthophylls --- natural compounds --- algae --- bioactive --- health --- neuroprotective agent --- neuroinflammation --- neurological diseases --- microalgae --- inflammation --- breast cancer --- bacterioruberin --- antioxidant --- pro-oxidant --- lutein --- β-carotene --- linolenic acid --- linoleic acid --- lipidic compounds --- PUFAs

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Blue biotechnology plays a major role in converting marine biomass into societal value, being a key pillar for many marine economy developmental frameworks and sustainability strategies, such as the Blue Growth Strategy, diverse Sea Basin Strategies (e.g., Atlantic Action Plan Priority 1 and 2 and COM (2017) 183), the Marine Strategy Framework Directive, the Limassol Declaration, or even the UN Sustainable Development 2030 Agenda. However, despite the recognized biotechnological potential of marine biomass, the work is dispersed between multiple areas of applied biotechnology, resulting in few concrete examples of product development.This book highlight the vast potential that marine resources hold, from viruses to seaweeds, and a myriad of applications from antimicrobials and cosmetics to feed and food that contributes to a market-driven and industrially orientated research, which will increase the efficiency of the marine biodiscovery pipeline and ultimately deliver realistic and measurable benefits to society, which is paramount for sustained blue growth and a successful market penetration of targeted biomolecules or enriched extracts for new product development, which are cornerstone issues for the present and the future of a marine biobased economy.

Technology: general issues --- microalgae --- fucoxanthin --- fatty acids --- antioxidant --- supercritical CO2 extraction --- co-solvent. --- Box-Behnken design --- extraction conditions --- bioactive compounds --- invasive seaweed --- cosmetics --- commercial microalgae cultivation --- dietary supplements --- lutein production --- marine microalgae --- Calliblepharis jubata --- aquaculture --- carbohydrates --- carrageenan --- Vibrio mediterranei --- giant phage --- complete genome --- skincare --- antioxidant activity --- antimicrobial activity --- cytotoxicity --- anti-enzymatic activity --- anti-inflammatory activity --- Phaedactylum tricornutum --- photochemistry --- single wavelength LEDs --- Rhodotorula sp. --- docosahexaenoic acid (DHA) --- carotenoids --- canthaxanthin --- raw glycerol --- microalgae --- fucoxanthin --- fatty acids --- antioxidant --- supercritical CO2 extraction --- co-solvent. --- Box-Behnken design --- extraction conditions --- bioactive compounds --- invasive seaweed --- cosmetics --- commercial microalgae cultivation --- dietary supplements --- lutein production --- marine microalgae --- Calliblepharis jubata --- aquaculture --- carbohydrates --- carrageenan --- Vibrio mediterranei --- giant phage --- complete genome --- skincare --- antioxidant activity --- antimicrobial activity --- cytotoxicity --- anti-enzymatic activity --- anti-inflammatory activity --- Phaedactylum tricornutum --- photochemistry --- single wavelength LEDs --- Rhodotorula sp. --- docosahexaenoic acid (DHA) --- carotenoids --- canthaxanthin --- raw glycerol

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Blue biotechnology plays a major role in converting marine biomass into societal value, being a key pillar for many marine economy developmental frameworks and sustainability strategies, such as the Blue Growth Strategy, diverse Sea Basin Strategies (e.g., Atlantic Action Plan Priority 1 and 2 and COM (2017) 183), the Marine Strategy Framework Directive, the Limassol Declaration, or even the UN Sustainable Development 2030 Agenda. However, despite the recognized biotechnological potential of marine biomass, the work is dispersed between multiple areas of applied biotechnology, resulting in few concrete examples of product development.This book highlight the vast potential that marine resources hold, from viruses to seaweeds, and a myriad of applications from antimicrobials and cosmetics to feed and food that contributes to a market-driven and industrially orientated research, which will increase the efficiency of the marine biodiscovery pipeline and ultimately deliver realistic and measurable benefits to society, which is paramount for sustained blue growth and a successful market penetration of targeted biomolecules or enriched extracts for new product development, which are cornerstone issues for the present and the future of a marine biobased economy.

microalgae --- fucoxanthin --- fatty acids --- antioxidant --- supercritical CO2 extraction --- co-solvent. --- Box–Behnken design --- extraction conditions --- bioactive compounds --- invasive seaweed --- cosmetics --- commercial microalgae cultivation --- dietary supplements --- lutein production --- marine microalgae --- Calliblepharis jubata --- aquaculture --- carbohydrates --- carrageenan --- Vibrio mediterranei --- giant phage --- complete genome --- skincare --- antioxidant activity --- antimicrobial activity --- cytotoxicity --- anti-enzymatic activity --- anti-inflammatory activity --- Phaedactylum tricornutum --- photochemistry --- single wavelength LEDs --- Rhodotorula sp. --- docosahexaenoic acid (DHA) --- carotenoids --- canthaxanthin --- raw glycerol --- n/a --- Box-Behnken design

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Carotenoids represent a large group of isoprenoid structures with many different structural characteristics and biological activities. They are the most important of the naturally occurring pigments and are responsible for the various colors of different fruits, vegetables, and plant parts. Marine carotenoids and their unique structures are responsible for the color of many fish, shellfish, and algae. However, while there have been many papers and reviews on carotenoids of terrestrial origin, there has been relatively little research conducted on the impact of marine carotenoids on human health. Recent research efforts have revealed that marine carotenoids have strong biological activity affecting human health and are candidates for nutraceuticals. This Topical Collection of Marine Drugs is dedicated to marine carotenoids, and will focus on the benefits of carotenoids for human beings. For a better understanding of the physiological effects of marine carotenoids, this collection should include the most recent developments in the presence, analysis, chemistry, and biochemistry of marine carotenoids.

fucoxanthin --- scopolamine --- acetylcholinesterase --- Alzheimer’s disease --- cognitive impairments --- mytiloxanthin --- anti-oxidative activity --- singlet oxygen --- hydroxyl radical --- lipid peroxidation --- astaxanthin production --- carotenoids --- genome-reduced Corynebacterium glutamicum --- systematic approach --- metabolic engineering --- marine microalgae --- seaweeds --- nonconventional extraction --- electrotechnologies --- pulsed electric field-assisted extraction --- supercritical fluid extraction --- green processing --- microwave-assisted extraction --- marine drugs --- Bangia fuscopurpurea --- red algae --- lycopene cyclase --- carotenoid --- metabolism --- astaxanthin --- Escherichia coli --- β-carotene ketolase --- β-carotene hydroxylase --- Haematococcus pluvialis --- PII signaling protein --- nitrogen starvation --- gene cloning --- mRNA expression --- microalgae --- anti-angiogenic --- cardioprotective activity --- anti-cancer --- anti-diabetic --- anti-inflammatory --- anti-obesity --- anti-oxidant --- beauty --- Phaeodactylum tricornutum --- spectrophotometry --- high through-put screening --- antioxidants --- bioactive compounds --- blue biotechnology --- marine microorganisms --- ozonolysis --- apo-fucoxanthinone --- Caco-2 --- antiproliferative effect --- Pyropia yezoensis --- α-cryptoxanthin --- zeinoxanthin --- lutein-5,6-epoxide --- antheraxanthin --- carotenoid synthesis pathway --- red seaweed --- human papillomavirus 16 (HPV16) --- astaxanthin (Asta) --- acrosome reaction --- cholera toxin subunit B (CTB) --- L1 protein --- cigarette smoke exposure --- p38 MAPK --- antioxidant inflammatory --- synaptic-associated plasticity --- comparative transcriptome analyses --- alcoholic liver disease --- bioinformatic analysis --- phytoene --- fluridone --- cosmeceuticals --- anti-obesity effect --- Phaeodactylum extract --- Coelastrum --- canthaxanthin --- lutein --- nanoemulsion --- sublingual delivery --- ascorbyl palmitate --- Franz cell --- alcoholic liver injury --- oxidative stress --- Nrf2 --- TLR4 --- chronic obstructive pulmonary disease --- nuclear factor erythroid 2-related factor 2 --- heme oxygenase-1 --- siphonaxanthin --- dehydro-metabolite --- white adipose tissue --- metabolic pathway in vivo --- stereochemistry --- Tigriopus --- copepod --- meso-zeaxanthin --- zeaxanthin --- reactive oxygen species --- immune system --- antioxidant --- antibiotics --- thermal stress --- disease --- halocynthiaxanthin --- intestinal absorption --- functional food --- apoptosis --- inflammation --- lipid metabolism --- high-fat diet

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U®), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development.

Medicine --- apoptosis --- fucoidan --- hepatocellular carcinoma --- reactive oxygen species --- 3-alkylpyridinium polymers --- nicotine --- nicotinic acetylcholine receptor --- non-small cell lung carcinoma --- melanoma --- sinulariolide --- proteomic --- mitochondria --- caspase cascade --- marine fungus --- sediment --- anthranilic acid --- Penicillium paneum --- cytotoxicity --- dibromotyrosine --- mitochondrial dysfunction --- oxidative stress --- topoisomerase --- epigonal organ --- bonnethead shark --- Jurkat --- tumor cell line --- hippuristanol --- PEL --- AP-1 --- STAT3 --- Akt --- colorectal cancer --- marine mollusc --- brominated indoles --- shrimp --- chemoprevention --- fatty acids --- carotenoids --- cancer --- nanoparticle --- osteosarcoma --- lung metastasis --- elisidepsin --- lipid rafts --- hydroxylated lipids --- fatty acid 2-hydroxylase --- cooperative binding --- membrane permeabilization --- marine organisms --- polysaccharides --- anticancer --- anticarcinogenic --- mechanisms of action --- fumigaclavine C --- anti-proliferation --- mitochondrial pathway --- anti-cancer --- anti-proliferative --- carotenoid --- cell cycle arrest --- fucoxanthin --- azoxymethane --- bioactive natural product --- isatin --- in vivo model --- Marthasterias glacialis L. --- palmitic acid --- ER-stress --- CHOP --- Antibody Drug Conjugates (ADCs) --- marine antitumor agents --- clinical trials --- approved antitumor agents --- AD0157 --- angiogenesis --- marine drug --- pyrrolidinedione --- secondary metabolites --- cancer preventive --- chemopreventive --- trabectedin --- plitidepsin --- tumor-associated macrophages --- tumor microenvironment --- preclinical --- anticancer immunity --- antiangiogenesis --- fascaplysin --- cyclin-dependent kinase --- small cell lung cancer --- camptothecin --- poly(ADP-ribose)-polymerase inhibitor --- breast cancer --- seaweed --- therapeutic compounds --- autophagy --- marine drugs --- autophagy inhibitors --- autophagy inducers --- macrolide --- programmed cell death --- energy stress --- araguspongine C --- c-Met --- HER2 --- gemcitabine --- pazopanib --- phase I --- safety --- soft tissue sarcoma --- pachastrissamine --- jaspine B --- carbocyclic analogue --- sphingosine kinase inhibitor --- molecular modeling --- ET-743 --- DNA minor groove binder --- soft tissue sarcoma --- chemotherapy --- bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM) --- anti-metastatic activity --- cell adhesion --- β1-integrin --- FAK --- BEL-7402 cell --- triterpene glycosides --- sea cucumbers --- antitumor activities --- arrest of cell cycle --- antibacterial --- marangucyclines --- deep-sea --- Streptomyces sp. SCSIO 11594 --- LS-1 --- SNU-C5/5-FU --- TGF-β signaling --- carcinoembryonic antigen --- kalkitoxin --- Moorea producens --- mitochondria toxin --- VEGF --- angiogenesis inhibitor --- hypoxia-inducible factor-1 --- HIF-1 --- Lyngbya majuscula --- marine metabolites --- SZ-685C --- nonfunctioning pituitary adenomas --- Ecklonia cava --- phlorotannins --- dieckol --- migration --- sipholenol A --- ABC transporter --- multidrug resistance --- P-gp/ABCB1 --- BCRP/ABCG2 --- MRP1/ABCC1 --- marine natural products --- glioblastoma --- xyloketal B --- proliferation --- TRPM7 --- marine compound --- ribosomal protein genes --- snoRNA --- FAU --- RPS30 --- SNORA62 --- evolution --- Porifera --- Penicillium brevicompactum --- Brevianamide --- Mycochromenic acid derivative --- antifouling --- Caribbean sponge --- plakortide --- endoperoxide --- leukemia --- multi-drug resistant leukemia --- Sarcophyton ehrenbergi --- soft coral --- terpenes --- cembranoids --- cytotoxic activity --- molecular docking --- uveal melanoma --- oxidative stress --- virtual screening --- Topo I inhibitor --- low toxic --- natural product --- Ulva fasciata --- selenium-containing polysaccharide-protein complex --- pseudopterosin --- NF-κB --- p65 --- inflammation --- cytokine release --- IL-6 --- TNFα --- MCP-1 --- glucocorticoid receptor --- paulomycins --- Micromonospora --- antitumor --- Cantabrian Sea-derived actinobacteria --- puupehenones --- sponges --- antiangiogenic --- antitumoral --- porifera/sponge --- cancer genes --- molecular oncology --- bromophenol --- molecular mechanisms --- cell cycle --- PI3K/Akt --- p38/ERK --- ROS --- human lung cancer --- glycosaminoglycans --- antiproliferative --- heparan sulphate --- gliotoxin --- NSCLC --- adriamycin resistance --- Sepia ink polysaccharides --- antitumour --- chemosensitization --- anticoagulation --- sea anemone --- drug discovery --- endothelial cells --- RGD motif --- kunitz type inhibitor --- prostate cancer --- antioxidant --- natural marine compounds --- marine biotechnology --- microalgae --- marine sponges --- Aeroplysinin --- Isofistularin --- pheochromocytoma and paraganglioma --- metastasis --- cancer progression --- cell adhesion molecules --- integrin β1 --- hypoxia --- phycocyanin --- non-small cell lung cancer --- NF-κB signaling --- marine-derived drugs --- bioanalysis --- chromatography --- manzamine A --- epithelial-mesenchymal transition --- lung cancer --- circulating tumor cells --- signal transduction --- cisplatin --- Lampetra morii --- buccal gland --- cystatin F --- anti-angiogenesis --- cystatin superfamily --- Antimicrobial peptide (AMP) --- Tilapia piscidin 4 (TP4) --- non-small cell lung cancer (NSCLC) --- itampolin A --- FBDD --- p38α --- novel inhibitor --- tetracenomycin X --- cyclin D1 --- proteasomal degradation --- p38 --- c-JUN --- λ-carrageenan --- heparanase --- anticoagulant --- depolymerisation --- cell migration --- Aspergillus --- naphthopyrones --- endophytic fungus --- Leathesia nana --- mangrove-derived actinomycete --- ansamycins --- divergolides --- apoptosis-inducing activity --- actinomycin --- EMT --- invasion --- low molecular weight fucoidan extract --- N-Ras --- neuroblastoma-rat sarcoma --- Cancer --- programmed cell death-ligand 1 --- programmed cell death-ligand 2 --- human sarcoma cell line (HT1080 cells) --- human normal diploid fibroblast (TIG-1 cells) --- chimera --- chemical conjugation --- anticancer agent --- hybridization --- α9-nicotinic acetylcholine receptors (nAChRs) --- breast cancer cells --- αO-conotoxin GeXIVA --- targeted therapy --- gorgonian --- Leptogorgia --- humulane sesquiterpenoids --- anticancer activity --- 12-deacetyl-12-epi-scalaradial --- HeLa cells --- Nur77 --- MAPK/ERK pathway --- Mycalin A --- C15 acetogenins --- synthetic analogues --- antiproliferative activity --- A375 and HeLa cell lines --- polyoxygenated steroids --- sponge --- Haliclona gracilis --- Thalassia testudinum --- thalassiolin B --- polyphenols --- CYP1A1 --- benzo[a]pyrene --- JNK1/2 --- natural products --- synergism --- A549 cells --- cytoskeleton --- P2X7 receptor --- pollution --- anti-angiogenic --- gene expression --- HSP90 --- inhibitor --- apoptosis --- fucoidan --- hepatocellular carcinoma --- reactive oxygen species --- 3-alkylpyridinium polymers --- nicotine --- nicotinic acetylcholine receptor --- non-small cell lung carcinoma --- melanoma --- sinulariolide --- proteomic --- mitochondria --- caspase cascade --- marine fungus --- sediment --- anthranilic acid --- Penicillium paneum --- cytotoxicity --- dibromotyrosine --- mitochondrial dysfunction --- oxidative stress --- topoisomerase --- epigonal organ --- bonnethead shark --- Jurkat --- tumor cell line --- hippuristanol --- PEL --- AP-1 --- STAT3 --- Akt --- colorectal cancer --- marine mollusc --- brominated indoles --- shrimp --- chemoprevention --- fatty acids --- carotenoids --- cancer --- nanoparticle --- osteosarcoma --- lung metastasis --- elisidepsin --- lipid rafts --- hydroxylated lipids --- fatty acid 2-hydroxylase --- cooperative binding --- membrane permeabilization --- marine organisms --- polysaccharides --- anticancer --- anticarcinogenic --- mechanisms of action --- fumigaclavine C --- anti-proliferation --- mitochondrial pathway --- anti-cancer --- anti-proliferative --- carotenoid --- cell cycle arrest --- fucoxanthin --- azoxymethane --- bioactive natural product --- isatin --- in vivo model --- Marthasterias glacialis L. --- palmitic acid --- ER-stress --- CHOP --- Antibody Drug Conjugates (ADCs) --- marine antitumor agents --- clinical trials --- approved antitumor agents --- AD0157 --- angiogenesis --- marine drug --- pyrrolidinedione --- secondary metabolites --- cancer preventive --- chemopreventive --- trabectedin --- plitidepsin --- tumor-associated macrophages --- tumor microenvironment --- preclinical --- anticancer immunity --- antiangiogenesis --- fascaplysin --- cyclin-dependent kinase --- small cell lung cancer --- camptothecin --- poly(ADP-ribose)-polymerase inhibitor --- breast cancer --- seaweed --- therapeutic compounds --- autophagy --- marine drugs --- autophagy inhibitors --- autophagy inducers --- macrolide --- programmed cell death --- energy stress --- araguspongine C --- c-Met --- HER2 --- gemcitabine --- pazopanib --- phase I --- safety --- soft tissue sarcoma --- pachastrissamine --- jaspine B --- carbocyclic analogue --- sphingosine kinase inhibitor --- molecular modeling --- ET-743 --- DNA minor groove binder --- soft tissue sarcoma --- chemotherapy --- bis (2,3-dibromo-4,5-dihydroxy-phenyl)-methane (BDDPM) --- anti-metastatic activity --- cell adhesion --- β1-integrin --- FAK --- BEL-7402 cell --- triterpene glycosides --- sea cucumbers --- antitumor activities --- arrest of cell cycle --- antibacterial --- marangucyclines --- deep-sea --- Streptomyces sp. SCSIO 11594 --- LS-1 --- SNU-C5/5-FU --- TGF-β signaling --- carcinoembryonic antigen --- kalkitoxin --- Moorea producens --- mitochondria toxin --- VEGF --- angiogenesis inhibitor --- hypoxia-inducible factor-1 --- HIF-1 --- Lyngbya majuscula --- marine metabolites --- SZ-685C --- nonfunctioning pituitary adenomas --- Ecklonia cava --- phlorotannins --- dieckol --- migration --- sipholenol A --- ABC transporter --- multidrug resistance --- P-gp/ABCB1 --- BCRP/ABCG2 --- MRP1/ABCC1 --- marine natural products --- glioblastoma --- xyloketal B --- proliferation --- TRPM7 --- marine compound --- ribosomal protein genes --- snoRNA --- FAU --- RPS30 --- SNORA62 --- evolution --- Porifera --- Penicillium brevicompactum --- Brevianamide --- Mycochromenic acid derivative --- antifouling --- Caribbean sponge --- plakortide --- endoperoxide --- leukemia --- multi-drug resistant leukemia --- Sarcophyton ehrenbergi --- soft coral --- terpenes --- cembranoids --- cytotoxic activity --- molecular docking --- uveal melanoma --- oxidative stress --- virtual screening --- Topo I inhibitor --- low toxic --- natural product --- Ulva fasciata --- selenium-containing polysaccharide-protein complex --- pseudopterosin --- NF-κB --- p65 --- inflammation --- cytokine release --- IL-6 --- TNFα --- MCP-1 --- glucocorticoid receptor --- paulomycins --- Micromonospora --- antitumor --- Cantabrian Sea-derived actinobacteria --- puupehenones --- sponges --- antiangiogenic --- antitumoral --- porifera/sponge --- cancer genes --- molecular oncology --- bromophenol --- molecular mechanisms --- cell cycle --- PI3K/Akt --- p38/ERK --- ROS --- human lung cancer --- glycosaminoglycans --- antiproliferative --- heparan sulphate --- gliotoxin --- NSCLC --- adriamycin resistance --- Sepia ink polysaccharides --- antitumour --- chemosensitization --- anticoagulation --- sea anemone --- drug discovery --- endothelial cells --- RGD motif --- kunitz type inhibitor --- prostate cancer --- antioxidant --- natural marine compounds --- marine biotechnology --- microalgae --- marine sponges --- Aeroplysinin --- Isofistularin --- pheochromocytoma and paraganglioma --- metastasis --- cancer progression --- cell adhesion molecules --- integrin β1 --- hypoxia --- phycocyanin --- non-small cell lung cancer --- NF-κB signaling --- marine-derived drugs --- bioanalysis --- chromatography --- manzamine A --- epithelial-mesenchymal transition --- lung cancer --- circulating tumor cells --- signal transduction --- cisplatin --- Lampetra morii --- buccal gland --- cystatin F --- anti-angiogenesis --- cystatin superfamily --- Antimicrobial peptide (AMP) --- Tilapia piscidin 4 (TP4) --- non-small cell lung cancer (NSCLC) --- itampolin A --- FBDD --- p38α --- novel inhibitor --- tetracenomycin X --- cyclin D1 --- proteasomal degradation --- p38 --- c-JUN --- λ-carrageenan --- heparanase --- anticoagulant --- depolymerisation --- cell migration --- Aspergillus --- naphthopyrones --- endophytic fungus --- Leathesia nana --- mangrove-derived actinomycete --- ansamycins --- divergolides --- apoptosis-inducing activity --- actinomycin --- EMT --- invasion --- low molecular weight fucoidan extract --- N-Ras --- neuroblastoma-rat sarcoma --- Cancer --- programmed cell death-ligand 1 --- programmed cell death-ligand 2 --- human sarcoma cell line (HT1080 cells) --- human normal diploid fibroblast (TIG-1 cells) --- chimera --- chemical conjugation --- anticancer agent --- hybridization --- α9-nicotinic acetylcholine receptors (nAChRs) --- breast cancer cells --- αO-conotoxin GeXIVA --- targeted therapy --- gorgonian --- Leptogorgia --- humulane sesquiterpenoids --- anticancer activity --- 12-deacetyl-12-epi-scalaradial --- HeLa cells --- Nur77 --- MAPK/ERK pathway --- Mycalin A --- C15 acetogenins --- synthetic analogues --- antiproliferative activity --- A375 and HeLa cell lines --- polyoxygenated steroids --- sponge --- Haliclona gracilis --- Thalassia testudinum --- thalassiolin B --- polyphenols --- CYP1A1 --- benzo[a]pyrene --- JNK1/2 --- natural products --- synergism --- A549 cells --- cytoskeleton --- P2X7 receptor --- pollution --- anti-angiogenic --- gene expression --- HSP90 --- inhibitor